Drug
Zp1848
Zp1848: highest development phase Phase 2, developed by Zealand Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZP1848 NCT02690025 | Phase 2 | Short Bowel Syndrome |
| ZP1848 NCT00868660 | Phase 1 | Inflammatory Bowel Disease |
Latest
No recent events.
Follow Zp1848 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.